This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ex-Dividend Stocks: Caterpillar, PerkinElmer

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

PerkinElmer

The laboratory services company is scheduled to report second-quarter earnings on Aug. 1. On average, analysts expect earnings of 49 cents a share on revenue of $539.5 million.

"PKI's genomics strategy centers on offering unique services for the front and back ends of the NGS workflow," Bank of America Merrill Lynch analysts wrote in a May 15 report. "At the front end, the recent Caliper acquisition provides automated liquid handling and NGS sample preparation solutions, and while this market has become more competitive, PKI noted that pricing remains healthy. Beyond NGS, Caliper also adds new in vivo imaging technologies that complement PKI's pharma portfolio. On the back end, PKI believes that its emerging informatics business will gain traction over time as it aids with data access, storage, transfer and analysis, with a goal of facilitating the transition of NGS into the clinic. Management believes that this is roughly a $500 market opportunity, and expects to launch new data analysis products later this year."

Forward Annual Dividend Yield: 1.1%

-- Written by Alexandra Zendrian



>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CAT $84.60 1.58%
PKI $51.51 1.02%
AAPL $127.60 2.28%
FB $83.09 2.87%
GOOG $535.38 2.16%

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs